ClinConnect ClinConnect Logo
Search / Trial NCT06372054

TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models

Launched by FONDAZIONE IRCCS CA' GRANDA, OSPEDALE MAGGIORE POLICLINICO · Apr 16, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Pilots Air Force Epigenetic Change Environmental Exposure

ClinConnect Summary

The TORNADO study is looking at how to create personalized risk models to understand health better, specifically for high-performance pilots in the Italian Air Force. The researchers aim to find out how various factors, such as biological samples (like urine, blood, and saliva) and lifestyle data, can help identify risks for conditions related to oxidative injury, stress, and cardiovascular health. By using advanced techniques, including artificial intelligence, the study aims to gather valuable insights that could improve health monitoring and prevention for both military personnel and the general public.

To be eligible for this study, participants need to be active members of the Italian Air Force, either in flight service or ground support, and between the ages of 26 and 38. They must agree to provide biological samples and use a wearable device to track their health exposure. Those selected will be part of a research process that collects data at different times, helping to uncover important health information. This study is currently recruiting participants who meet these criteria and is an exciting opportunity to contribute to advancements in personalized medicine.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being part of the Italian Air Force, as in active flight service or ground staff
  • Age between 26 and 38 years
  • Consent to collect biological samples and use the wearable device to monitor exposure parameters
  • Exclusion Criteria:
  • Age \< 25 years and \> 39 years
  • no signature on informed consent

About Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico is a prestigious research and clinical care institution based in Milan, Italy. Renowned for its commitment to advancing medical knowledge and improving patient outcomes, the foundation integrates cutting-edge research with high-quality healthcare services. It serves as a hub for innovative clinical trials, fostering collaborations among healthcare professionals, researchers, and academic institutions. With a focus on various therapeutic areas, the foundation aims to translate scientific discoveries into effective treatments, ultimately enhancing the quality of life for patients.

Locations

Milan, , Italy

Patients applied

0 patients applied

Trial Officials

Giovanni Marfia, MD, PhD

Principal Investigator

Fondazione IRCCs Ca' Granda Ospedale MAggiore Policlinico, Italian Air Force

Emanuele Garzia, MD, PhD

Study Chair

Italian Air Force

Marco Locatelli, MD, PhD

Study Chair

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Francesco Vestito, PhD

Study Chair

Italian Air Force

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported